Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Increased prostate gland volume 30 cc to 80 cc post void residual volume 50 ml to 200 ml IPSS SCORE MORE THAN 8
Exclusion criteria
Exclusion criteria: k/c/o Bladder or prostate carcinoma. Urinary bladder calculus Acute and chronic renal failure k/c/o Stricture urethra Patients with prior history of prostatic/urethral surgery or other invasive procedure to treat BPH. Males who participated in any other clinical trials in last 90 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in prostate gland volume will be assessed using Transabdominal Ultrasonogram before and after treatment.Timepoint: 1 year 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Reduction in International Prostate Symptom Score [IPSS SCORE] before and after treatment.For clinical significance IPSS MCID is 3 point decrease compared to baseline. 2.Reduction in Post Void Residual Urine Volume [PVR] will be assessed using Transabdominal Ultrasonogram before and after treatment. Timepoint: 1 year 6 months | — |
Countries
India
Contacts
National Institute of Siddha